Homology Medicines Probability of Future Stock Price Finishing Over 1.56
| FIXXDelisted Stock | USD 1.09 0.06 5.83% |
Homology |
Homology Medicines Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Homology Medicines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Homology Medicines can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Homology Medicines is now traded under the symbol QTTB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Homology Medicines is not yet fully synchronised with the market data | |
| Homology Medicines has some characteristics of a very speculative penny stock | |
| Homology Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (95.14 M). | |
| Homology Medicines currently holds about 201.07 M in cash with (96.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Homology Medicines Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Homology Stock often depends not only on the future outlook of the current and potential Homology Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Homology Medicines' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.8 M | |
| Cash And Short Term Investments | 82.7 M |
Homology Medicines Technical Analysis
Homology Medicines' future price can be derived by breaking down and analyzing its technical indicators over time. Homology Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Homology Medicines. In general, you should focus on analyzing Homology Stock price patterns and their correlations with different microeconomic environments and drivers.
Homology Medicines Predictive Forecast Models
Homology Medicines' time-series forecasting models is one of many Homology Medicines' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Homology Medicines' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Homology Medicines
Checking the ongoing alerts about Homology Medicines for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Homology Medicines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Homology Medicines is now traded under the symbol QTTB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Homology Medicines is not yet fully synchronised with the market data | |
| Homology Medicines has some characteristics of a very speculative penny stock | |
| Homology Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (95.14 M). | |
| Homology Medicines currently holds about 201.07 M in cash with (96.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Homology Stock
If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |